摘要
| Figures/TablesFigures/Tables | ReferencesReferences
Summary
Anandamide, an endogenous agonist of CB1 receptors, also activates TRPV1 but at a higher concentration. Studies demonstrate the anticonvulsant activity of anandamide via CB1 receptors, while its action through TRPV1 is still ambiguous. Thus, the present study investigated the influence of anandamide on pentylenetetrazole-induced seizures in mice pretreated with TRPV1 or CB1 receptor antagonists. Acute intracerebroventricular administration of low doses of anandamide (10, 20, or 40 渭g/mouse) produced anticonvulsant effect, while the pro-convulsant effect was evident at high doses (80 or 100 渭g/mouse). Interestingly, AM251 (2 渭g/mouse), a CB1 antagonist pretreatment blocked the anticonvulsant effect, but augmented the pro-convulsant effect. Conversely, in the presence of inactive dose of capsazepine (1 渭g/mouse), a TRPV1 antagonist, anandamide exhibited significant anticonvulsant effect even at high doses with no change in its anticonvulsant effect. Moreover, mice treated with capsaicin, a TRPV1 agonist (10, or 100 渭g/mouse) exhibited pro-convulsant activity that was blocked by capsazepine pretreatment. However, capsazepine, per se at doses 10 or 100 渭g/mouse exhibited anticonvulsant effect. Like anandamide, the agents (AM404 and URB597), which increase its synaptic concentrations produced similar biphasic effects. Thus, these results indicate that anandamide exhibits both pro- and anticonvulsant activities by activating TRPV1 and CB1 receptor respectively.
